Page last updated: 2024-08-17

cycloserine and Panic Disorder

cycloserine has been researched along with Panic Disorder in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (26.67)29.6817
2010's9 (60.00)24.3611
2020's2 (13.33)2.80

Authors

AuthorsStudies
Alavi, N; Baird, SO; Dutcher, CD; Kauffman, BY; Lee-Furman, E; Otto, MW; Papini, S; Piper, ME; Rosenfield, B; Rosenfield, D; Smits, JAJ; Zvolensky, MJ1
Browning, M; Harmer, CJ; Nickless, A; Reinecke, A1
Cath, DC; Denys, DA; Duits, P; Hofmeijer-Sevink, MK; Hoogendoorn, AW; Rijkeboer, MM; van Balkom, AJ; van den Hout, MA; van Megen, HJ; Vulink, NC1
Carpenter, A; Leyfer, O; Pincus, D1
Alt, I; Fehm, L; Fydrich, T; Mumm, J; Plag, J; Pyrkosch, L; Ströhle, A1
Kauffman, BY; Lee-Furman, E; Otto, MW; Piper, ME; Powers, MB; Rosenfield, D; Smits, JA; Zvolensky, MJ1
Dowd, SM; Gueorguieva, R; Hofmann, SG; Krystal, JH; Otto, MW; Pearlson, G; Pollack, MH; Simon, NM; Szuhany, KL; Tolin, DF1
Cordioli, AV; Heldt, E; Manfro, GG; Otto, MW1
Basden, S; Eisenmenger, K; Hofmann, SG; Krystal, JH; Meunier, SA; Otto, MW; Pearlson, GD; Pollack, MH; Simon, NM; Tolin, DF1
Diemer, J; Domschke, K; Vennewald, N; Zwanzger, P1
Choi, DC; Gerardi, M; Ressler, KJ; Rothbaum, BO1
Finck, C; Golfels, F; Halisch, A; Plag, J; Räth, D; Siegmund, A; Ströhle, A1
Birk, L1
Deveney, C; Otto, MW1
Hofmann, SG1

Reviews

6 review(s) available for cycloserine and Panic Disorder

ArticleYear
[Cognitive-behavioral therapy in panic disorder].
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30 Suppl 2

    Topics: Agoraphobia; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Humans; Panic Disorder; Recurrence; Treatment Outcome

2008
Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety.
    European archives of psychiatry and clinical neuroscience, 2010, Volume: 260 Suppl 2

    Topics: Antimetabolites; Biomedical Research; Cognition; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Panic Disorder; Transcranial Magnetic Stimulation

2010
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
    Current topics in behavioral neurosciences, 2010, Volume: 2

    Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Eye Movement Desensitization Reprocessing; Humans; Hypnosis; Implosive Therapy; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome

2010
Pharmacotherapy for performance anxiety disorders: occasionally useful but typically contraindicated.
    Journal of clinical psychology, 2004, Volume: 60, Issue:8

    Topics: Antimetabolites; Anxiety Disorders; Cycloserine; Extinction, Psychological; Fear; Humans; Panic Disorder; Speech; Task Performance and Analysis

2004
Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies.
    The Journal of clinical psychiatry, 2005, Volume: 66 Suppl 4

    Topics: Antidepressive Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost-Benefit Analysis; Cycloserine; Humans; Panic Disorder; Treatment Outcome

2005
Enhancing exposure-based therapy from a translational research perspective.
    Behaviour research and therapy, 2007, Volume: 45, Issue:9

    Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders

2007

Trials

8 trial(s) available for cycloserine and Panic Disorder

ArticleYear
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
    Drug and alcohol dependence, 2020, 03-01, Volume: 208

    Topics: Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Pilot Projects; Smokers; Smoking; Smoking Cessation; Smoking Reduction; Treatment Outcome; Young Adult

2020
Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
    Behaviour research and therapy, 2020, Volume: 129

    Topics: Adult; Amygdala; Attentional Bias; Brain; Cycloserine; Drug Partial Agonism; Female; Functional Neuroimaging; Humans; Implosive Therapy; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Panic Disorder; Reaction Time; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Treatment Outcome

2020
No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
    Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:5

    Topics: Adult; Agoraphobia; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Panic Disorder; Treatment Outcome; Young Adult

2017
N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
    Child psychiatry and human development, 2019, Volume: 50, Issue:2

    Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Fear; Female; Humans; Implosive Therapy; Male; N-Methylaspartate; Panic Disorder; Parents; Psychotropic Drugs; Treatment Outcome

2019
Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
    Contemporary clinical trials, 2016, Volume: 48

    Topics: Antimetabolites; Cycloserine; Double-Blind Method; Humans; Implosive Therapy; Panic Disorder; Smoking; Smoking Cessation

2016
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
    Depression and anxiety, 2016, Volume: 33, Issue:8

    Topics: Adult; Antimetabolites; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Treatment Outcome; Young Adult

2016
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
    Biological psychiatry, 2010, Feb-15, Volume: 67, Issue:4

    Topics: Adult; Analysis of Variance; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Severity of Illness Index; Young Adult

2010
D-cycloserine does not improve but might slightly speed up the outcome of in-vivo exposure therapy in patients with severe agoraphobia and panic disorder in a randomized double blind clinical trial.
    Journal of psychiatric research, 2011, Volume: 45, Issue:8

    Topics: Adult; Agoraphobia; Analysis of Variance; Antimetabolites; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Psychometrics; Statistics, Nonparametric; Treatment Outcome; Young Adult

2011

Other Studies

1 other study(ies) available for cycloserine and Panic Disorder

ArticleYear
Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Journal of psychiatric research, 2018, Volume: 105

    Topics: Adult; Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Excitatory Amino Acid Agonists; Extinction, Psychological; Female; Follow-Up Studies; Humans; Implosive Therapy; Male; Middle Aged; Outcome Assessment, Health Care; Panic Disorder; Receptors, N-Methyl-D-Aspartate

2018
chemdatabank.com